CEO Jonas Graversen MSci PhD















Jonas Graversen graduated as a Master of Science in 1997 and obtained his PhD in Molecular Biology from University of Aarhus in 2000 based on a thesis on protein-protein interactions, co-inventor of trimerisation and CTLD binder technology acquired by Anaphore Inc., La Jolla, CA.  He has extensive research experience within the field of protein design and function and has published more than 25 scientific papers and patents. He has 11 years of industrial experience working in biotech companies (ProteoPharma, Borean Pharma and Symphogen, Copenhagen) as well as in the pharmaceutical industry (Novo Nordisk, Copenhagen), working both within discovery and development projects. He was co-founder of Proteopharma in 2000.



Affinicon ApS Science Park Aarhus, Aabogade 15, 8200 Aarhus N